The effect of Memantine on cognition disorders induced by Electroconvulsive therapy (ECT)

Phase 2

Recruiting

• Conditions: Post ECT cognition disorders; Mental Health - Other mental health disorders

• Registration Number: ACTRN12614000619640
• Lead Sponsor: Mohammad Abbasinazari

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-06-11
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

All patients between 18-60 years old undergoing ECT in the psychosomatic ward of Taleghani hospital(Tehran, Iran) with informed consent

Exclusion Criteria

patients with renal failure or hepatic failure, those with cardiac block, patients using medications with anticholinergic or NMDA(N-methyl D aspartate) antagonistic effect,pregnant and brearstfeeding women

Study & Design

• Study Type: Interventional
• Study Design: Not specified